Germline TP53 Variants and Susceptibility to Osteosarcoma

Lisa Mirabello, Meredith Yeager, Phuong L. Mai, Julie M. Gastier-Foster, Richard Gorlick, Chand Khanna, Ana Patiño-Garcia, Luis Sierrasesúmaga, Fernando Lecanda, Irene L. Andrulis, Jay S. Wunder, Nalan Gokgoz, Donald A. Barkauskas, Xijun Zhang, Aurelie Vogt, Kristine Jones, Joseph F. Boland, Stephen J. Chanock, Sharon A. Savage

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The etiologic contribution of germline genetic variation to sporadic osteosarcoma is not well understood. Osteosarcoma is a sentinel cancer of Li-Fraumeni syndrome (LFS), in which approximately 70% of families meeting the classic criteria have germline TP53 mutations. We sequenced TP53 exons in 765 osteosarcoma cases. Data were analyzed with χ<sup>2</sup> tests, logistic regression, and Cox proportional hazards regression models. We observed a high frequency of young osteosarcoma cases (age <30 years) carrying a known LFS- or likely LFS-associated mutation (3.8%) or rare exonic variant (5.7%) with an overall frequency of 9.5%, compared with none in case patients age 30 years and older (P <. 001). This high TP53 mutation prevalence in young osteosarcoma cases is statistically significantly greater than the previously reported prevalence of 3% (P =. 0024). We identified a novel association between a TP53 rare variant and metastasis at diagnosis of osteosarcoma (rs1800372, odds ratio = 4.27, 95% confidence interval = 1.2 to 15.5, P =. 026). Genetic susceptibility to young onset osteosarcoma is distinct from older adult onset osteosarcoma, with a high frequency of LFS-associated and rare exonic TP53 variants.

Original languageEnglish (US)
Article numberdjv101
JournalJournal of the National Cancer Institute
Volume107
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Osteosarcoma
Li-Fraumeni Syndrome
Mutation
Germ-Line Mutation
Genetic Predisposition to Disease
Proportional Hazards Models
Exons
Logistic Models
Odds Ratio
Confidence Intervals
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Mirabello, L., Yeager, M., Mai, P. L., Gastier-Foster, J. M., Gorlick, R., Khanna, C., ... Savage, S. A. (2015). Germline TP53 Variants and Susceptibility to Osteosarcoma. Journal of the National Cancer Institute, 107(7), [djv101]. https://doi.org/10.1093/jnci/djv101

Germline TP53 Variants and Susceptibility to Osteosarcoma. / Mirabello, Lisa; Yeager, Meredith; Mai, Phuong L.; Gastier-Foster, Julie M.; Gorlick, Richard; Khanna, Chand; Patiño-Garcia, Ana; Sierrasesúmaga, Luis; Lecanda, Fernando; Andrulis, Irene L.; Wunder, Jay S.; Gokgoz, Nalan; Barkauskas, Donald A.; Zhang, Xijun; Vogt, Aurelie; Jones, Kristine; Boland, Joseph F.; Chanock, Stephen J.; Savage, Sharon A.

In: Journal of the National Cancer Institute, Vol. 107, No. 7, djv101, 01.07.2015.

Research output: Contribution to journalArticle

Mirabello, L, Yeager, M, Mai, PL, Gastier-Foster, JM, Gorlick, R, Khanna, C, Patiño-Garcia, A, Sierrasesúmaga, L, Lecanda, F, Andrulis, IL, Wunder, JS, Gokgoz, N, Barkauskas, DA, Zhang, X, Vogt, A, Jones, K, Boland, JF, Chanock, SJ & Savage, SA 2015, 'Germline TP53 Variants and Susceptibility to Osteosarcoma', Journal of the National Cancer Institute, vol. 107, no. 7, djv101. https://doi.org/10.1093/jnci/djv101
Mirabello L, Yeager M, Mai PL, Gastier-Foster JM, Gorlick R, Khanna C et al. Germline TP53 Variants and Susceptibility to Osteosarcoma. Journal of the National Cancer Institute. 2015 Jul 1;107(7). djv101. https://doi.org/10.1093/jnci/djv101
Mirabello, Lisa ; Yeager, Meredith ; Mai, Phuong L. ; Gastier-Foster, Julie M. ; Gorlick, Richard ; Khanna, Chand ; Patiño-Garcia, Ana ; Sierrasesúmaga, Luis ; Lecanda, Fernando ; Andrulis, Irene L. ; Wunder, Jay S. ; Gokgoz, Nalan ; Barkauskas, Donald A. ; Zhang, Xijun ; Vogt, Aurelie ; Jones, Kristine ; Boland, Joseph F. ; Chanock, Stephen J. ; Savage, Sharon A. / Germline TP53 Variants and Susceptibility to Osteosarcoma. In: Journal of the National Cancer Institute. 2015 ; Vol. 107, No. 7.
@article{1af7cae11615460ba53efde66e6a1617,
title = "Germline TP53 Variants and Susceptibility to Osteosarcoma",
abstract = "The etiologic contribution of germline genetic variation to sporadic osteosarcoma is not well understood. Osteosarcoma is a sentinel cancer of Li-Fraumeni syndrome (LFS), in which approximately 70{\%} of families meeting the classic criteria have germline TP53 mutations. We sequenced TP53 exons in 765 osteosarcoma cases. Data were analyzed with χ2 tests, logistic regression, and Cox proportional hazards regression models. We observed a high frequency of young osteosarcoma cases (age <30 years) carrying a known LFS- or likely LFS-associated mutation (3.8{\%}) or rare exonic variant (5.7{\%}) with an overall frequency of 9.5{\%}, compared with none in case patients age 30 years and older (P <. 001). This high TP53 mutation prevalence in young osteosarcoma cases is statistically significantly greater than the previously reported prevalence of 3{\%} (P =. 0024). We identified a novel association between a TP53 rare variant and metastasis at diagnosis of osteosarcoma (rs1800372, odds ratio = 4.27, 95{\%} confidence interval = 1.2 to 15.5, P =. 026). Genetic susceptibility to young onset osteosarcoma is distinct from older adult onset osteosarcoma, with a high frequency of LFS-associated and rare exonic TP53 variants.",
author = "Lisa Mirabello and Meredith Yeager and Mai, {Phuong L.} and Gastier-Foster, {Julie M.} and Richard Gorlick and Chand Khanna and Ana Pati{\~n}o-Garcia and Luis Sierrases{\'u}maga and Fernando Lecanda and Andrulis, {Irene L.} and Wunder, {Jay S.} and Nalan Gokgoz and Barkauskas, {Donald A.} and Xijun Zhang and Aurelie Vogt and Kristine Jones and Boland, {Joseph F.} and Chanock, {Stephen J.} and Savage, {Sharon A.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1093/jnci/djv101",
language = "English (US)",
volume = "107",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Germline TP53 Variants and Susceptibility to Osteosarcoma

AU - Mirabello, Lisa

AU - Yeager, Meredith

AU - Mai, Phuong L.

AU - Gastier-Foster, Julie M.

AU - Gorlick, Richard

AU - Khanna, Chand

AU - Patiño-Garcia, Ana

AU - Sierrasesúmaga, Luis

AU - Lecanda, Fernando

AU - Andrulis, Irene L.

AU - Wunder, Jay S.

AU - Gokgoz, Nalan

AU - Barkauskas, Donald A.

AU - Zhang, Xijun

AU - Vogt, Aurelie

AU - Jones, Kristine

AU - Boland, Joseph F.

AU - Chanock, Stephen J.

AU - Savage, Sharon A.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The etiologic contribution of germline genetic variation to sporadic osteosarcoma is not well understood. Osteosarcoma is a sentinel cancer of Li-Fraumeni syndrome (LFS), in which approximately 70% of families meeting the classic criteria have germline TP53 mutations. We sequenced TP53 exons in 765 osteosarcoma cases. Data were analyzed with χ2 tests, logistic regression, and Cox proportional hazards regression models. We observed a high frequency of young osteosarcoma cases (age <30 years) carrying a known LFS- or likely LFS-associated mutation (3.8%) or rare exonic variant (5.7%) with an overall frequency of 9.5%, compared with none in case patients age 30 years and older (P <. 001). This high TP53 mutation prevalence in young osteosarcoma cases is statistically significantly greater than the previously reported prevalence of 3% (P =. 0024). We identified a novel association between a TP53 rare variant and metastasis at diagnosis of osteosarcoma (rs1800372, odds ratio = 4.27, 95% confidence interval = 1.2 to 15.5, P =. 026). Genetic susceptibility to young onset osteosarcoma is distinct from older adult onset osteosarcoma, with a high frequency of LFS-associated and rare exonic TP53 variants.

AB - The etiologic contribution of germline genetic variation to sporadic osteosarcoma is not well understood. Osteosarcoma is a sentinel cancer of Li-Fraumeni syndrome (LFS), in which approximately 70% of families meeting the classic criteria have germline TP53 mutations. We sequenced TP53 exons in 765 osteosarcoma cases. Data were analyzed with χ2 tests, logistic regression, and Cox proportional hazards regression models. We observed a high frequency of young osteosarcoma cases (age <30 years) carrying a known LFS- or likely LFS-associated mutation (3.8%) or rare exonic variant (5.7%) with an overall frequency of 9.5%, compared with none in case patients age 30 years and older (P <. 001). This high TP53 mutation prevalence in young osteosarcoma cases is statistically significantly greater than the previously reported prevalence of 3% (P =. 0024). We identified a novel association between a TP53 rare variant and metastasis at diagnosis of osteosarcoma (rs1800372, odds ratio = 4.27, 95% confidence interval = 1.2 to 15.5, P =. 026). Genetic susceptibility to young onset osteosarcoma is distinct from older adult onset osteosarcoma, with a high frequency of LFS-associated and rare exonic TP53 variants.

UR - http://www.scopus.com/inward/record.url?scp=84938099717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938099717&partnerID=8YFLogxK

U2 - 10.1093/jnci/djv101

DO - 10.1093/jnci/djv101

M3 - Article

C2 - 25896519

AN - SCOPUS:84938099717

VL - 107

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 7

M1 - djv101

ER -